The top 10 pharma companies have all collaborated with or acquired AI technologies: Novartis, Roche, Pfizer, Merck, AstraZeneca, GSK, Sanofi, Abbvie, Bristol-Myers Squibb, and Johnson & Johnson. Reports projecting where the industry would be in terms of artificial intelligence (AI) in 2020 predicted that AI and machine learning were set to transform the pharmaceutical industry … in the near future. Rock Health has monitored investments within the digital health ecosphere since 2011, and it reports that investments have started to shift into the pharmaceutical arena, mostly within the categories of R&D, clinical trials, and digital therapeutics, which includes using AI. According to a 2017 report by Pharma IQ, 95% of the pharma professionals surveyed expected the impact of intelligent enterprise technologies to take hold in the wider drug development industry over the next three years, with one-fifth of the respondents believing that the industry was on the cusp of a revolution. The cusp is here now and will continue to grow into 2020.
Dec-16-2019, 13:19:35 GMT